This is a research-driven the pharmaceutical company in America. This company recently introduced a highly anticipated drug to treat severe atopic dermatitis called Upadacitinib. This is what has granted AbbVie a breakthrough therapy designation by the FDA. The company portfolio spans multiple areas such as dermatology, gastroenterology, oncology, and neurology. This has boosted its revenue to about $28.22 billion dollars.